Literature DB >> 8397098

Receptor-mediated stimulation and inhibition of nerve growth factor secretion by vascular smooth muscle.

J B Tuttle1, R Etheridge, D J Creedon.   

Abstract

Nerve growth factor (NGF) is a potent neurotrophin signaling protein, the best-known member of a family of similar neurotrophins. Specific neuronal populations depend upon the neurotrophins for normal function and disturbances in NGF and neurotrophin supply have been implicated in neurodegenerative disease, diabetes, and hypertension. This report details experiments in which the hourly pattern of NGF secretion by cultured vascular smooth muscle cells is examined. Vascular smooth muscle cells are major innervation targets of the neuronal population first discovered to be NGF-dependent: the sympathetic principal neurons. The results show that arginine vasopressin (AVP), angiotensin II (AngII), and alpha-adrenergic receptor activation, all contractile stimuli, elevate NGF secretion. However, AVP dependably does so alone while AngII requires coactivation of adenosine receptors. Adenosine alone inhibits secretion and the alpha-adrenergic increase in NGF output can be antagonized by activation of beta-adrenergic receptors. A change to fresh culture medium is also a potent stimulus to increased NGF output.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397098     DOI: 10.1006/excr.1993.1256

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  Sputa nerve growth factor forms a preferable substitute to mouse 7S-beta nerve growth factor.

Authors:  Dawn C-I Koh; A Armugam; K Jeyaseelan
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

Review 2.  The sympathetic nervous system and pain.

Authors:  Tanja Schlereth; Frank Birklein
Journal:  Neuromolecular Med       Date:  2007-11-08       Impact factor: 3.843

Review 3.  Cardiovascular actions of neurotrophins.

Authors:  Andrea Caporali; Costanza Emanueli
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

4.  Repeated local administration of noradrenaline or saline inhibits thermal hyperalgesia in pain-sensitized human skin.

Authors:  P D Drummond; D M Lipnicki
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

5.  The effect of noradrenaline, angiotensin II and vasopressin on blood flow and sensitivity to heat in capsaicin-treated skin.

Authors:  P D Drummond
Journal:  Clin Auton Res       Date:  1998-04       Impact factor: 4.435

6.  Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury.

Authors:  M J Donovan; R C Miranda; R Kraemer; T A McCaffrey; L Tessarollo; D Mahadeo; S Sharif; D R Kaplan; P Tsoulfas; L Parada
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

7.  Engineered zinc finger protein-mediated VEGF-a activation restores deficient VEGF-a in sensory neurons in experimental diabetes.

Authors:  Elizabeth J Pawson; Beatriz Duran-Jimenez; Richard Surosky; Heather E Brooke; S Kaye Spratt; David R Tomlinson; Natalie J Gardiner
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.